B2
Enzyme engineering · Directed evolution
Carbon–halogen bond cleavage for remediation and industrial process chemistry. Directed
evolution, ribosome display and catalytic optimisation applied to your substrate — relevant
wherever a process generates or handles halogenated streams.
- Biocatalysis
- Bioremediation
- Green chemistry
- Evidence
- Capability & method data under NDA
- Stage
- Pilot-ready · licensing open
- Indicative
- € 15 000 – 120 000negotiable by scope and application
B3
Protein biophysics · Formulation support
Know before you formulate. DSC, fluorescence probes and dynamic light scattering map
thermodynamic and kinetic stability; buffer, salt and pH screening and aggregation risk
profiling are run on your protein rather than on a generic prediction.
- Thermal stability
- Aggregation risk
- Buffer optimisation
- Evidence
- Method portfolio · report under NDA
- Stage
- Pilot-ready
- Indicative
- € 8 000 – 50 000negotiable by scope and application
B4
Protease activity · Condition optimisation
Kosmotropic anions increase HRV 3C protease rigidity, stability and catalytic efficiency — a
published finding with direct workflow consequences. If your production depends on a cleavage
step, this tells you which conditions maximise yield and enzyme lifetime.
- Protease workflow
- Salt screening
- Enzyme stability
- Evidence
- Peer-reviewed 2022 (Biophys. Chem.)
- Stage
- Pilot-ready
- Indicative
- € 6 000 – 35 000negotiable by scope and application
B5
Recombinant protein purification
One-step affinity purification and immobilisation for MBP-tagged proteins. The MBP tag
substantially improves solubility for difficult-to-express fusion partners — a cost-effective
alternative for teams spending too much on multi-step chromatography of insoluble targets.
- MBP tag
- Enhanced solubility
- One-step purification
- Evidence
- Method portfolio · report under NDA
- Stage
- Pilot-ready
- Indicative
- € 5 000 – 40 000negotiable by scope and application
B7
Aggregation · Self-assembly
Aggregation quietly kills promising protein therapeutics and formulations. The platform screens
stress conditions, maps aggregation kinetics and identifies stabilisation strategies. It also
covers spider-silk self-assembly systems for biomedical and biomaterial applications.
- Aggregation assay
- Neurodegeneration research
- Advanced biomaterials
- Evidence
- Method portfolio · report under NDA
- Stage
- Pilot-ready · licensing open
- Indicative
- € 8 000 – 60 000negotiable by scope and application
C1Fluorescent probe
APF · C26H17NO5 · MW 433.42 g/mol
Cell-permeable, photostable probe for selective detection of highly reactive oxygen and
nitrogen species. On reaction with hROS/hRNS it is cleaved to release free fluorescein, giving a
strong signal on standard microscopes, flow cytometers and plate readers.
- hROS / hRNS detection
- Live-cell imaging
- Flow cytometry
- HCS antioxidant screening
- Selectivity
- OCl⁻ · HO· · ONOO⁻
- Stage
- Synthesis to order
- Indicative
- Price on requestby quantity and application
C2
NPF · C26H15NO7 · MW 463.40 g/mol
A substrate and reporter group for enzymatic and bioanalytical assays. Enzyme-mediated
hydrolysis or reduction of the nitrophenyl ester bond changes absorbance and fluorescence,
producing an optical signal proportional to enzyme activity or analyte concentration.
- Enzyme activity reporter
- Esterase substrates
- Hydrolase profiling
- Plate-reader compatible
- Readout
- Absorbance · fluorescence
- Stage
- Synthesis to order
- Indicative
- Price on requestby quantity and application
C7Bioconjugation tools
Saccharide derivatives · Reactive intermediates
Sugar isothiocyanates form covalent bonds with amines, which makes them useful for conjugating
sugars to proteins or fluorescent labels and tracking sugar transport in vivo. Aminosugars are
building blocks for glycoprotein and glycolipid synthesis, joint-nutrition compounds and
antibiotic development targeting bacterial cell walls.
- Bioconjugation
- Glycoprotein synthesis
- Glycolipid building blocks
- Antibiotic development
- Chondroprotectives
- Evidence
- Synthetic capability · characterisation on request
- Stage
- Synthesis to order · licensing open
- Indicative
- Price on requestcustom quantities available